Cholangiocarcinoma (CCA) is a highly-aggressive malignancy arising from the biliary tree,
characterized by a steady increase in incidence globally and a high mortality rate. Most …

Primary tumor resection and liver transplantation are the only curative treatment options for
the management of cholangiocarcinoma (CCA). However, for patients with advanced or …

Cholangiocarcinoma (CCA) comprises a heterogeneous group of cancers with pathologic
features of biliary tract differentiation, and is best classified anatomically as intrahepatic CCA …

Cholangiocarcinoma (CCA) is a relatively rare malignancy that arises from the epithelial
cells of the intrahepatic, perihilar and distal biliary tree. Intrahepatic CCA (ICC) represents …

Introduction: Surgical resection remains the mainstay of potentially curative treatment in the
early stages of cholangiocarcinoma, whereas for the advanced stage, systemic …

Cholangiocarcinoma (CCA) is a rare cancer arising from the biliary tree with a poor
prognosis and limited therapeutic options. Recent large scale molecular characterisation …

Cholangiocarcinomas (CCA) are rare tumors of the liver with poor prognosis. The standard
of care in patients with unresectable tumors or metastatic disease is combination …

Cholangiocarcinoma (CCA) includes a cluster of highly heterogeneous biliary malignant
tumours that can arise at any point of the biliary tree. Their incidence is increasing globally …

Cholangiocarcinoma is a deadly cancer comprising very heterogenous subtypes with a
limited therapeutic arsenal in all comers. However, recent significant advances were made …

Introduction Biliary tract cancer represents a heterogeneous group of malignancies
characterized by dismal prognosis and scarce therapeutic options. Area covered In the last …